SCHEMBL7337580

SCHEMBL7337580

CC(C)[C@H](NC(=O)N(C)Cc1ccccn1)C(=O)N[C@@H](Cc1ccccc1)[C@H](O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)N1CCN(C)CC1)C(C)C

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.79
CYP3A4 P08684 8/20 0.41
CYP2D6 P10635 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
MAPT P10636 2/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CTSD P07339 1/20 0.39
CTSS P25774 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HSD17B10 Q99714 1/20 0.38
SLC22A2 O15244 1/20 0.38
SLC22A1 O15245 1/20 0.38
ABCC3 O15438 1/20 0.38
ABCC4 O15439 1/20 0.38
MLNR O43193 1/20 0.38
NR1I2 O75469 1/20 0.38
SLCO2B1 O94956 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
A-76928 SCHEMBL6449595 0.89 CA2 (1.00) CA2CYP3A4CYP2D6CYP1A2CYP2C19
A-77003 SCHEMBL6448973 0.89 CA2 (1.00) CA2CYP3A4CYP2D6CYP1A2CYP2C19
A-77003 SCHEMBL7337518 0.89 CA2 (1.00) CA2CYP3A4CYP2D6CYP1A2CYP2C19
A-77003 SCHEMBL8749867 0.89 CA2 (1.00) CA2CYP3A4CYP2D6CYP1A2CYP2C19
A-77003 SCHEMBL2770013 0.89 CA2 (1.00) CA2CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL7336293 0.88 CA2 (0.61) CA2CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL7278095 0.87 CA2 (0.96) CA2CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL7338355 0.85 CA2 (0.52) CA2CYP3A4CYP2D6CYP2C19CTSD
SCHEMBL7341491 0.84 CA2 (0.89) CA2CYP3A4CYP2D6CYP1A2CYP2C19
SCHEMBL7331008 0.84 CA2 (0.89) CA2CYP3A4CYP2D6CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed